000 | 01924 a2200505 4500 | ||
---|---|---|---|
005 | 20250515185434.0 | ||
264 | 0 | _c20091203 | |
008 | 200912s 0 0 eng d | ||
022 | _a1522-1490 | ||
024 | 7 |
_a10.1152/ajpregu.91040.2008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChen, Shuzhen | |
245 | 0 | 0 |
_aIschemia-induced brain damage is enhanced in human renin and angiotensinogen double-transgenic mice. _h[electronic resource] |
260 |
_bAmerican journal of physiology. Regulatory, integrative and comparative physiology _cNov 2009 |
||
300 |
_aR1526-31 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAngiotensin II _xmetabolism |
650 | 0 | 4 |
_aAngiotensin II Type 1 Receptor Blockers _xpharmacology |
650 | 0 | 4 |
_aAngiotensinogen _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBlood Pressure _xphysiology |
650 | 0 | 4 |
_aBrain _xblood supply |
650 | 0 | 4 |
_aBrain Ischemia _xetiology |
650 | 0 | 4 |
_aCell Death _xphysiology |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInfarction, Middle Cerebral Artery _xcomplications |
650 | 0 | 4 |
_aLosartan _xpharmacology |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Transgenic |
650 | 0 | 4 |
_aReceptor, Angiotensin, Type 1 _xdrug effects |
650 | 0 | 4 |
_aRegional Blood Flow _xphysiology |
650 | 0 | 4 |
_aRenin _xgenetics |
650 | 0 | 4 | _aSeverity of Illness Index |
650 | 0 | 4 |
_aSignal Transduction _xphysiology |
700 | 1 | _aLi, Guangze | |
700 | 1 | _aZhang, Wenfeng | |
700 | 1 | _aWang, Jinju | |
700 | 1 | _aSigmund, Curt D | |
700 | 1 | _aOlson, James E | |
700 | 1 | _aChen, Yanfang | |
773 | 0 |
_tAmerican journal of physiology. Regulatory, integrative and comparative physiology _gvol. 297 _gno. 5 _gp. R1526-31 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1152/ajpregu.91040.2008 _zAvailable from publisher's website |
999 |
_c19156876 _d19156876 |